ABSTRACT
Background and Aim: Celiac disease (CD) has proinflammatory and pathogenic immune responses to gluten in intestinal tissue, leading to structural changes in the mucosa of the small intestine. The association of human leukocyte antigen (HLA)-DQ2 and DQ8 genotypes with CD has been previously reported. This test has a negative predictive value close to 100%, so its main purpose is to rule out the detection of CD completely or almost completely. There is limited information regarding HLA-DQ4/5 in CD. This study was conducted to determine the HLA-DQ4/5 genotypes in a group of Southwestern Iranian children with CD. Methods: We conducted a case-control study in Southwest Iran involving 100 participants, employing a nonprobabilistic sampling method. Samples were taken from participants' oral buccal mucosa at Imam Sajjad Hospital of Yasuj, Iran. Then DNA was extracted from these samples and used to determine the frequency of HLA-DQ4/5 genotypes through Sequence-Specific Primer-Polymerase Chain Reaction assay. SPSS 20 was utilized for statistical analyses. Results: Fifty diagnosed patients with CD (high anti-tissue transglutaminase [tTG]-IgA level [upper limit of normal] with pathological findings of Marsh III) and 50 non-CD individuals (normal anti-tTG-IgA level and normal total IgA level) were enrolled in the study from August 5, 2022 to October 15, 2023. Findings showed that the DQ4a*4b allele has the highest frequency in the CD samples (78%, p < 0.01) followed by the DQ5a*5b allele (12%, p < 0.01). Additionally, there was a higher prevalence of DQ4/DQ5 in patients with CD compared to controls (odds ratio = 6.5, confidence interval = 0.84 to 69.46, p < 0.01). Furthermore, a significant association was found among HLA DQ4/5 genotype, age (>9.5) (p < 0.01), and gender (female) (p < 0.05). Conclusion: The observed significant differences among HLA-DQ4 and HLA-DQ5 in Iranian CD samples against controls and the high value of the relative risks showed the significant function of the studied alleles in the prevalence of CD in Iranian patients.
ABSTRACT
In recent years, because of the various functions associated with silver nanoparticles (AgNPs) in manufacturing, different ways for their synthesis have been established. The antioxidant and antibacterial effects of terebinth (Pistacia terebinthus) have been proven. In this study, for the first time, using the extract of terebinth, we have synthesized AgNPs using a green method. Ultraviolet-visible spectrophotometry, X-ray diffraction (XRD), Infrared spectroscopy (FTIR), and the field emission scanning electron microscopy (FE-SEM) spectroscopy analyses were applied to evaluate and verify the formation of NPs, and the antioxidant, antibacterial and anticancer activity of synthesized AgNPs was also studied. The highest absorption was obtained 24 h following the synthesis at 420 nm because of the Ag + to Ag0 reduction. The functional groups stabilizing activity was obtained by FTIR. Moreover, size and surface morphology were assessed by FE-SEM. The present research showed the AgNPs had spherical shape and had a 32 nm diameter. The face-centered cubic construction of AgNPs was evaluated through XRD method with peaks at 2θ = 37°, 49°, 63°, and 76° (related to the planes of silver 111, 200, 220, 311), respectively. Antimicrobial assessment revealed that the biosynthesized AgNPs had a great antimicrobial activity in response to Gram-positive and Gram-negative strains. Suppression of 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity was determined to be associated with dosage. In addition, a high anticancer activity, against MCF-7 cell line, was observed for the 25 µg/mL concentration of the AgNPs. Altogether, these results show that biogenic AgNPs can be functioned as beneficial medicinal compounds.
